SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
21 of
21
|
CHAIRS WELCOME TO VIRTUAL CROI 2021
Sharon L. Hillier
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
INTRODUCTION TO THE MARTIN DELANEY PRESENTATION
James Pickett
AIDS Foundation of Chicago, Chicago, IL, USA
VACCINE NATIONALISM IS KILLING US: HOW INEQUITIES IN RESEARCH AND ACCESS TO SARS-COV-2 VACCINES WILL PERPETUATE THE PANDEMIC (ABSTRACT
2a)
Gregg S. Gonsalves
Yale University, New Haven, CT, USA
Fatima Hassan
Health Justice Initiative, Cape Town, South Africa
INTRODUCTION TO THE BERNARD FIELDS LECTURE
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
NEUTRALIZING ANTIBODIES AGAINST CORONAVIRUSES (ABSTRACT
3)
Pamela J Bjorkman
California Institute of Technology, Pasadena, CA, USA
INTRODUCTION TO THE N'GALY-MANN LECTURE
Elaine J Abrams
Columbia University, New York, NY, USA
Tedros Adhanom Ghebreyesus
World Health Organization, Geneva, Switzerland
LESSONS FROM THE CONCURRENT HIV/AIDS AND COVID-19 PANDEMICS: A TWO-WAY STREET (ABSTRACT
4)
Anthony S Fauci
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
SESSION OVERVIEW
Robert T Schooley
University of California San Diego, La Jolla, CA, USA
David L Thomas
The Johns Hopkins School of Medicine, Baltimore, MD, USA
RAPID GENOMIC SEQUENCING FOR MANAGEMENT OF COVID-19 (ABSTRACT
11)
Kwok-Yung Yuen
The University of Hong Kong, Hong Kong, Hong Kong
COVID-19: A HOSPITALISED UNWELL PATIENT WITH PNEUMONITIS (ABSTRACT
12)
Sanjay Bhagani
Royal Free Hospital, London, United Kingdom
CRITICAL CARE OF COVID-19 (ABSTRACT
13)
Janhavi Athale
Mayo Clinic Arizona, Phoenix, AZ, USA
QUESTIONS AND ANSWERS WITH THE AUDIENCE
SESSION OVERVIEW
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
Richard E Chaisson
The Johns Hopkins University, Baltimore, MD, USA
MAKING SENSE OF STUDY DESIGN DIFFERENCES BETWEEN COVID-19 PLATFORM TRIALS (ABSTRACT
9)
Lori Dodd
National Institutes of Health, Bethesda, MD, USA
DESIGN OF CURRENT AND FUTURE COVID-19 VACCINE EFFICACY TRIALS (ABSTRACT
10)
Holly Janes
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
LIVE QUESTIONS AND ANSWERS WITH THE AUDIENCE
SESSION OVERVIEW
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Frank Kirchhoff
Ulm University Medical Center, Ulm, Germany
STRUCTURES OF SARS-COV-2 ANTIBODIES INDUCED BY INFECTION AND MRNA VACCINES (ABSTRACT
5)
Christopher O Barnes
California Institute of Technology, Pasadena, CA, USA
EMERGING CONCEPTS IN HIV-1 RESTRICTION (ABSTRACT
6)
Edward Campbell
Loyola University Chicago, Maywood, IL, USA
SARS-COV-2 SPECIFIC AND CROSS-REACTIVE T CELL RESPONSES (ABSTRACT
7)
Daniela Weiskopf
La Jolla Institute for Immunology, La Jolla, CA, USA
ARTIFICIAL INTELLIGENCE-INSPIRED ANTIBODY ENGINEERING (ABSTRACT
8)
Sai Reddy
ETH Zurich, Basel, Switzerland
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
21 of
21
|
